Jin Medical International Ltd., a foreign private issuer, has filed a report with the United States Securities and Exchange Commission (SEC) for the month of March 2024, indicating a change of auditor. The company's previous auditor, DNTW Toronto LLP, resigned on February 26, 2024, effective immediately, from auditing the financial statements for the year ended September 30, 2023. There were no disagreements or reportable events between Jin Medical International and DNTW during the period from September 23, 2023, to February 28, 2024. Subsequently, on March 1, 2024, the company's Audit Committee appointed Audit Alliance LLP as the new independent registered public accounting firm. The company confirms that there were no consultations with DNTW regarding any reportable events during the two fiscal years ended December 31, 2023, and 2022, up to the date of the new auditor's appointment. The report was signed by Erqi Wang, Chief Executive Officer of Jin Medical International Ltd., on March 1, 2024.

Jin Medical International Ltd., a foreign private issuer, has filed a report with the United States Securities and Exchange Commission (SEC) for the month of March 2024, indicating a change of auditor. The company's previous auditor, DNTW Toronto LLP, resigned on February 26, 2024, effective immediately, from auditing the financial statements for the year ended September 30, 2023. There were no disagreements or reportable events between Jin Medical International and DNTW during the period from September 23, 2023, to February 28, 2024. Subsequently, on March 1, 2024, the company's Audit Committee appointed Audit Alliance LLP as the new independent registered public accounting firm. The company confirms that there were no consultations with DNTW regarding any reportable events during the two fiscal years ended December 31, 2023, and 2022, up to the date of the new auditor's appointment. The report was signed by Erqi Wang, Chief Executive Officer of Jin Medical International Ltd., on March 1, 2024.